SANOFINSESanofi India Limited· PharmaceuticalsLowNeutral
Announced Thu, 16 Oct · 13:19 IST

Sanofi India Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanofi India Limited has filed a disclosure with the stock exchange under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations. Regulation 30 requires listed companies to inform the exchange about material events or developments that could affect share price or shareholder decisions. The filing as provided does not contain specific details about the nature of the disclosure, such as whether it relates to a management change, financial result, corporate action, or other material event. Investors should check the detailed filing on the NSE/BSE portal for the specific information shared.

Likely market impact

The actual impact on shareholders depends on what the disclosure contains, which is not visible in this filing summary. This is a routine compliance filing and may or may not be material to the stock price.